Several NIH officials last week warned the FDA commissioner against approving the use of convalescent plasma to treat the coronavirus.
The Food and Drug Administration announced Sunday that it had authorized an emergency use declaration for convalescent plasma to treat. FDA commissioner Dr. Stephen Hahn said that early trials indicate a 35% better chance of survival when convalescent plasma is used in “optimal patients.” President Trump held a news conference with Hahn at the White House shortly after the FDA announced the emergency authorization. The two left as multiple reporters shouted “was there pressure on you to authorize this?” CBS News’ Weijia Jiang reported last week that National Institute of Health director Dr.
